The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma

BACKGROUND: Studies are trying to add immunotherapy to gemcitabine and cisplatin (GP) induction chemotherapy, the standard therapy, in nasopharyngeal carcinoma (NPC) patients with locoregionally advanced disease. However, how the immune system responds to GP remains unknown. METHOD: We examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao‐Min, Zhang, Xiao‐Min, Li, Jun‐Yan, Jiang, Ning, Chen, Lei, Tang, Ling‐Long, Mao, Yan‐Ping, Li, Wen‐Fei, Zhou, Guan‐Qun, Li, Ying‐Qin, Liu, Na, Zhang, Yuan, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487869/
https://www.ncbi.nlm.nih.gov/pubmed/35355438
http://dx.doi.org/10.1002/cam4.4705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487869/
https://www.ncbi.nlm.nih.gov/pubmed/35355438
http://dx.doi.org/10.1002/cam4.4705

Ejemplares similares